Liu Mei-Hua — Contributing Editor

I am a Hong Kong contributing editor for Gangnam Meditour, the English-language Korea medical-tourism directory operated by HEIM GLOBAL under KHIDI registration A-2026-04-02-06873. Most of my writing for the wider network appears on our stem-cell editorial archive, where I have served as lead editor since the archive was founded; this contributing-editor page on the directory itself collects the cross-published essays and reference notes that fit the directory's broader medical-tourism frame. My background is in the Hong Kong luxury aesthetic press — fifteen years of editorial work for the kind of magazines one used to find on the lower lobby coffee tables at the Mandarin Oriental and the Peninsula, the kind that took the wellness category seriously before it was a category. The remit on this page is editorial rather than promotional. I do not rank clinics, I do not write under a clinic's brief, and the framework I use to assess a Seoul clinic is the same framework a senior Hong Kong editor would have used to assess a Tsim Sha Tsui beauty institute thirty years ago — the lobby, the lift attendant, the way tea is offered, the way the consent paperwork is laid out.

Background and editorial training

I trained at the kind of Hong Kong luxury monthly that took editorial standards seriously — bylines under sub-editors who had themselves trained at Tatler Asia and at the South China Morning Post's lifestyle pages in their broadsheet-era seriousness. The beat in those years covered the aesthetic and wellness layer of the city — the dermatologists at Lee Garden Three, the slow facialists in the Central Tower buildings, the cosmetic-surgery referral networks running between Hong Kong and Seoul, and the longevity-and-cell-therapy practitioners who began to emerge as the Mainland regenerative-medicine market matured. I wrote in that period in both English and Cantonese, with occasional Mandarin work for the Greater Bay Area editions. The transition to a contributing-editor role at the Gangnam-stem-cell archive in 2025 was a natural continuation; the editorial framework — the assumption that the reader has already travelled, has already been somewhere comparable, and is now interested in the smaller distinctions that separate one tier from the next — translates cleanly from luxury aesthetic monthlies to a Korean medical-tourism directory.

What I cover for Gangnam Meditour

My beat for the directory covers four overlapping registers. Regenerative cell therapies as practised in Korean clinics — autologous and allogeneic protocols, exosome adjunct work, the laboratory and quality-control layer that distinguishes the better Seoul practices from the broader market. The hospitality and travel layer of medical tourism between Hong Kong, the Greater Bay Area, and Seoul — hotels, transit, the practical logistics of clinic-day pacing, the recovery-friendly cafés and walks. The cross-cultural sociology of Cantonese, Mainland Mandarin, and Korean patient communities — how the consultation room actually works when a Hong Kong patient meets a Gangnam practice, where the language and cultural translation tends to break down, and what a good international-patient coordinator does to bridge it. And the editorial-standards layer — what verification looks like, how I cross-check device platform claims against manufacturer lists, how I think about commercial relationships relative to editorial inclusion.

How I approach a clinic assessment

The framework I use is conservative and slow. A clinic enters my editorial coverage when three conditions are met. First, the clinic must be a registered Korean medical institution verifiable through the Health Insurance Review and Assessment Service registry and through KHIDI's foreign-patient-attraction portal. Second, the specific physician I am writing about must hold a current Korean medical licence verifiable through the Korean Medical Association registry, with the licence number on record. Third, any device platform the clinic claims to operate — Ultherapy, Ultherapy PRIME, Thermage FLX, Sofwave — must appear on the manufacturer's authorised-provider list at the clinic's name and address. Where any of the three conditions fail, the clinic does not enter the coverage. The framework is more conservative than the legal floor under the Medical Service Act; it is the framework I would have applied at a Hong Kong luxury monthly and the framework I apply now. I do not publish numbered rankings of individual practices; what I publish are editorial shortlists with documented reasons, revisited quarterly.

Editorial independence and commercial disclosure

Some of the clinics I write about maintain commercial relationships with HEIM GLOBAL, the publisher behind both Gangnam Meditour and the stem-cell archive. These relationships are typically referral arrangements where international patients who contact the clinic through a network link generate a referral fee. The arrangements are disclosed on the [commercial disclosure page](/disclosure/) and on each affected article. Editorial inclusion is independent of commercial relationships in the specific senses laid out in our [editorial policy](/editorial-policy/) — clinics that decline commercial arrangements are not excluded from coverage, clinics that fail editorial standards are not included even where they offer commercial arrangements, and the order or framing of editorial coverage is not adjusted in exchange for commercial consideration. Outbound commercial links carry the appropriate sponsored attributes. My byline appears on editorial pieces only; promotional or sponsored content, where it exists on the network, does not run under contributing-editor bylines.

Voice, language, and writing register

I write in British English for the directory and the stem-cell archive, with sparing Cantonese inserts where the texture genuinely demands it — typically one or two per long-form piece, never as decoration. The voice is slower than typical SEO writing and the cadence is closer to a magazine essay than to a listicle. Sentence length varies deliberately; the rhythm is the rhythm of a Hong Kong editor reading aloud, not of a marketing brief. I avoid the imperatives that mark much wellness writing — "discover," "unlock," "transform." The remit is to write with the assumption that the reader is intelligent, has travelled, and is making a real decision; the editorial obligation is to provide the information the decision actually needs rather than the information that flatters the marketing arc. Where I make a recommendation, the reasons are documented. Where I withhold a recommendation, the reasons for that are also documented.

Where to find my longer work

The bulk of my long-form writing lives at the stem-cell editorial archive, where I serve as lead editor. The archive covers regenerative-medicine protocols in greater clinical and laboratory depth than fits the broader medical-tourism directory frame — autologous expansion versus allogeneic sourcing, the cell-counting and quality-control layer, exosome adjunct protocols, the laboratory infrastructure question, the cost-transparency picture, and the comparative work between Korean, Japanese, Singaporean, and Thai regenerative-medicine practice. Readers interested in the broader medical-tourism context — visa logistics, transit, hotels, language coverage, refund and dispute pathways — will find that on this directory. The two publications are deliberately complementary; the archive goes deeper on the regenerative-medicine register and the directory goes wider on the medical-travel register.

“The luxury here is undramatic. The lobby is quiet, the lift attendant remembers your appointment, the consent paperwork is laid out without ceremony. There is no signage one cannot ignore.”

Liu Mei-Hua, on the Apgujeong clinic strip

Frequently asked questions

Are you a clinician?

No. I am an editor, not a clinician. Nothing I write should be treated as medical advice. My work is editorial reportage in the wellness and medical-travel register, drawing on physician interviews, manufacturer documentation, public regulatory records, and direct site visits. Where clinical specifics matter to a reader's decision, the relevant clinician at the relevant Korean clinic is the source of truth, not me.

What is your relationship to HEIM GLOBAL?

I am a contributing editor to publications operated by HEIM GLOBAL, including Gangnam Meditour (this site) and gangnam-stem-cell.com (where I serve as lead editor). HEIM GLOBAL is a KHIDI-registered medical-tourism facilitator (A-2026-04-02-06873). My editorial work is independent of HEIM GLOBAL's commercial relationships with clinics, in the senses documented on the editorial policy page. My byline appears on editorial pieces only.

Do you accept payment from clinics for coverage?

No. I do not accept payment from clinics for inclusion, framing, or favourable coverage. HEIM GLOBAL operates commercial referral arrangements with some of the clinics covered on the network; those arrangements are disclosed and are independent of editorial decisions. The framework is documented on the editorial policy and commercial disclosure pages.

Why do you write in English on a Korea-based publication?

Gangnam Meditour is an English-language directory built for international readers planning medical-tourism trips to Korea — Hong Kong, Singapore, Taiwan, Malaysia, the Gulf, the United States, and Europe. The .kr top-level domain reflects that the publisher is Korea-based; the editorial register is English because the readership is international. My own background is bilingual English-Cantonese with working Mandarin; the English register here is the British English I learned and have written in for two decades.

How do I read more of your work?

The longest-form work lives at the stem-cell editorial archive (gangnam-stem-cell.com), where I serve as lead editor. Cross-published essays appear on this directory under my byline. New essays publish roughly weekly across the network; the editorial policy page documents the revision and correction process.

Can I contact you directly with a story tip or correction?

Yes. Editorial enquiries for the Gangnam Meditour byline reach me through the editorial team at the directory; corrections to pieces that originated on the stem-cell archive should reach the archive's editorial address. The corrections workflow is documented on the editorial policy page — we aim to respond to factual-error reports within five business days and to revise in place with a dated correction note where warranted.